{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:24:00Z","timestamp":1772501040265,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["402364\/2021-0"],"award-info":[{"award-number":["402364\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["404610\/2021-8"],"award-info":[{"award-number":["404610\/2021-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10738-2","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:53:34Z","timestamp":1751086414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The rs3757385 polymorphism increases IRF5 expression and systemic nitric oxide metabolites, protecting urothelial bladder cancer patients from recurrence"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5428-311X","authenticated-orcid":false,"given":"Ariane P.","family":"Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7488-5760","authenticated-orcid":false,"given":"Isabely M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1181-7617","authenticated-orcid":false,"given":"Beatriz G. L.","family":"Vacario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-8524","authenticated-orcid":false,"given":"Alexsandro","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3666-2399","authenticated-orcid":false,"given":"Rafael G.","family":"Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-2505","authenticated-orcid":false,"given":"Carolina","family":"Coradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2565-4396","authenticated-orcid":false,"given":"Emily M. S.","family":"Wrzesinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-8998","authenticated-orcid":false,"given":"Guilherme L.","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-6782","authenticated-orcid":false,"given":"Andrea N. C.","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4023-9548","authenticated-orcid":false,"given":"Marcell A. B.","family":"Lozovoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-8621","authenticated-orcid":false,"given":"Roberta L.","family":"Guembarovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-4369","authenticated-orcid":false,"given":"Carolina","family":"Panis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-5807","authenticated-orcid":false,"given":"Juliana Mara","family":"Serpeloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"10738_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"10738_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","volume":"82","author":"GJ Netto","year":"2022","unstructured":"Netto GJ, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, Hoon P, Tan SK, Tickoo T, Tsuzuki S, Turajlic I, Cree H, Moch (2022) The 2022 world health organization classification of tumors of the urinary system and male genital Organs\u2014Part B: prostate and urinary tract tumors. Eur Urol 82:469\u2013482. https:\/\/doi.org\/10.1016\/j.eururo.2022.07.002","journal-title":"Eur Urol"},{"key":"10738_CR3","doi-asserted-by":"publisher","unstructured":"Raspollini MR, Comperat EM, Lopez-Beltran A, Montironi R, Cimadamore A, Tsuzuki T, Netto GJ (2023) News in the classification of WHO 2022 bladder tumors, Pathologica 1\u20139. https:\/\/doi.org\/10.32074\/1591-951X-838","DOI":"10.32074\/1591-951X-838"},{"key":"10738_CR4","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.3390\/cancers14205019","volume":"14","author":"AT Shalata","year":"2022","unstructured":"Shalata AT, Shehata M, Van Bogaert E, Ali KM, Alksas A, Mahmoud A, El-Gendy EM, Mohamed MA, Giridharan GA, Contractor S, El-Baz A (2022) Predicting recurrence of Non-Muscle-Invasive bladder cancer: current techniques and future trends. Cancers 14:5019. https:\/\/doi.org\/10.3390\/cancers14205019","journal-title":"Cancers"},{"key":"10738_CR5","doi-asserted-by":"publisher","first-page":"802","DOI":"10.21037\/tau-24-150","volume":"13","author":"Z-Z Ma","year":"2024","unstructured":"Ma Z-Z, Yang D-D, Niu M-E, Lu X-M, Du Y-T, Chin P, Ding Y-H, Qian C-Y (2024) Construction of early warning classification of risk in bladder spasm and its intervention plans guided by the rate adjustment card of continuous bladder irrigation after transurethral resection of the prostate (TURP): development and usability study. Transl Androl Urol 13:802\u2013811. https:\/\/doi.org\/10.21037\/tau-24-150","journal-title":"Transl Androl Urol"},{"key":"10738_CR6","unstructured":"Kaseb H, Leslie SW, Soon-Sutton TL, Aeddula NR (2024) Bladder Cancer, in: StatPearls, StatPearls Publishing, Treasure Island (FL). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536923\/ (accessed July 27, 2024)"},{"key":"10738_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"10738_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/pme.11.15","volume":"8","author":"J Gu","year":"2011","unstructured":"Gu J, Wu X (2011) Genetic susceptibility to bladder Cancer risk and outcome. Personalized Med 8:365\u2013374. https:\/\/doi.org\/10.2217\/pme.11.15","journal-title":"Personalized Med"},{"key":"10738_CR9","doi-asserted-by":"publisher","first-page":"93279","DOI":"10.18632\/oncotarget.21565","volume":"8","author":"X Sui","year":"2017","unstructured":"Sui X, Lei L, Chen L, Xie T, Li X (2017) Inflammatory microenvironment in the initiation and progression of bladder cancer. Oncotarget 8:93279\u201393294. https:\/\/doi.org\/10.18632\/oncotarget.21565","journal-title":"Oncotarget"},{"key":"10738_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00428-015-1820-x","volume":"467","author":"G Nesi","year":"2015","unstructured":"Nesi G, Nobili S, Cai T, Caini S, Santi R (2015) Chronic inflammation in urothelial bladder cancer. Virchows Arch 467:623\u2013633. https:\/\/doi.org\/10.1007\/s00428-015-1820-x","journal-title":"Virchows Arch"},{"key":"10738_CR11","doi-asserted-by":"publisher","unstructured":"Leibovici D, Grossman HB, Dinney CP, Millikan RE, Lerner S, Wang Y, Gu J, Dong Q, Wu X (2005) Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. 23:5746\u20135756. https:\/\/doi.org\/10.1200\/JCO.2005.01.598","DOI":"10.1200\/JCO.2005.01.598"},{"key":"10738_CR12","first-page":"6424","volume":"63","author":"BJ Barnes","year":"2003","unstructured":"Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM (2003) Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell Death1. Cancer Res 63:6424\u20136431","journal-title":"Cancer Res"},{"key":"10738_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-67199-4","volume-title":"Encyclopedia of signaling molecules","year":"2018","unstructured":"Choi S (ed) (2018) Encyclopedia of signaling molecules. Springer International Publishing, Cham. https:\/\/doi.org\/10.1007\/978-3-319-67199-4"},{"key":"10738_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1128\/JVI.02276-15","volume":"90","author":"JL Proenca-Modena","year":"2016","unstructured":"Proenca-Modena JL, Hyde JL, Sesti-Costa R, Lucas T, Pinto AK, Richner JM, Gorman MJ, Lazear HM, Diamond MS (2016) Interferon-Regulatory factor 5-Dependent signaling restricts orthobunyavirus dissemination to the central nervous system. J Virol 90:189\u2013205. https:\/\/doi.org\/10.1128\/JVI.02276-15","journal-title":"J Virol"},{"key":"10738_CR15","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1074\/jbc.M804744200","volume":"284","author":"G Hu","year":"2009","unstructured":"Hu G, Barnes BJ (2009) IRF-5 is a mediator of the death Receptor-induced apoptotic signaling pathway. J Biol Chem 284:2767\u20132777. https:\/\/doi.org\/10.1074\/jbc.M804744200","journal-title":"J Biol Chem"},{"key":"10738_CR16","doi-asserted-by":"publisher","unstructured":"Yanai H, Chen H, Inuzuka T, Kondo S, Mak T.W., Takaoka A, Honda K, Taniguchi T (2007) Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci U S A 104:3402\u20133407. https:\/\/doi.org\/10.1073\/pnas.0611559104","DOI":"10.1073\/pnas.0611559104"},{"key":"10738_CR17","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1038\/ncomms7676","volume":"6","author":"G Lu","year":"2015","unstructured":"Lu G, Zhang R, Geng S, Peng L, Jayaraman P, Chen C, Xu F, Yang J, Li Q, Zheng H, Shen K, Wang J, Liu X, Wang W, Zheng Z, Qi C-F, Si C, He JC, Liu K, Lira SA, Sikora AG, Li L, Xiong H (2015) Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization. Nat Commun 6:6676. https:\/\/doi.org\/10.1038\/ncomms7676","journal-title":"Nat Commun"},{"key":"10738_CR18","doi-asserted-by":"publisher","first-page":"15557","DOI":"10.1038\/s41598-024-66168-w","volume":"14","author":"BK Roberts","year":"2024","unstructured":"Roberts BK, Li DI, Somerville C, Matta B, Jha V, Steinke A, Brune Z, Blanc L, Soffer SZ, Barnes BJ (2024) IRF5 suppresses metastasis through the regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation. Sci Rep 14:15557. https:\/\/doi.org\/10.1038\/s41598-024-66168-w","journal-title":"Sci Rep"},{"key":"10738_CR19","doi-asserted-by":"publisher","first-page":"888713","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L (2022) Of Tumor-Associated macrophages in Cancer immunotherapy. Front Immunol 13:888713. https:\/\/doi.org\/10.3389\/fimmu.2022.888713","journal-title":"Front Immunol"},{"key":"10738_CR20","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3390\/ijms19123805","volume":"19","author":"Q Xue","year":"2018","unstructured":"Xue Q, Yan Y, Zhang R, Xiong H (2018) Regulation of iNOS on immune cells and its role in diseases. IJMS 19:3805. https:\/\/doi.org\/10.3390\/ijms19123805","journal-title":"IJMS"},{"key":"10738_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/1817-1737.65036","volume":"5","author":"F Masri","year":"2010","unstructured":"Masri F (2010) Role of nitric oxide and its metabolites as potential markers in lung cancer. Ann Thorac Med 5:123. https:\/\/doi.org\/10.4103\/1817-1737.65036","journal-title":"Ann Thorac Med"},{"key":"10738_CR22","first-page":"6502","volume":"50","author":"S Franceschi","year":"1990","unstructured":"Franceschi S, Talamini R, Barra S, Bar\u00f3n AE, Negri E, Bidoli E, Serraino D (1990) La vecchia, smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in Northern Italy. Cancer Res 50:6502\u20136507","journal-title":"Cancer Res"},{"key":"10738_CR23","doi-asserted-by":"publisher","unstructured":"Schuster SL, Hsieh AC (2019) The untranslated regions of mRNAs in cancer, trends in Cancer 5. 245\u2013262. https:\/\/doi.org\/10.1016\/j.trecan.2019.02.011","DOI":"10.1016\/j.trecan.2019.02.011"},{"key":"10738_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/08820139.2016.1225759","volume":"46","author":"R Amiri Jahromi","year":"2017","unstructured":"Amiri Jahromi R, Nasiri M, Jahromi AR (2017) Interferon regulatory factor 5 gene polymorphisms in Iranian women with unexplained recurrent pregnancy loss. Immunol Investig 46:97\u2013107. https:\/\/doi.org\/10.1080\/08820139.2016.1225759","journal-title":"Immunol Investig"},{"key":"10738_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3899\/jrheum.091163","volume":"37","author":"P Dieude","year":"2010","unstructured":"Dieude P, Dawidowicz K, Guedj M, Legrain Y, Wipff J, Hachulla E, Diot E, Sibilia J, Mouthon L, Cabane J, Amoura Z, Crakowski J-L, Carpentier P, Avouac J, Meyer O, Kahan A, Boileau C, Allanore Y (2010) Phenotype-Haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. J Rheumatol 37:987\u2013992. https:\/\/doi.org\/10.3899\/jrheum.091163","journal-title":"J Rheumatol"},{"key":"10738_CR26","doi-asserted-by":"publisher","DOI":"10.25143\/prom-rsu_2020-12-dts","author":"J Zepa","year":"2020","unstructured":"Zepa J (2020) The relationship of candidate gene polymorphisms with ankylosing spondylitis and its clinical course. Summary Doctoral Thesis Ph D R\u012bga Stradi\u0146\u0161 Univ. https:\/\/doi.org\/10.25143\/prom-rsu_2020-12-dts","journal-title":"Summary Doctoral Thesis Ph D R\u012bga Stradi\u0146\u0161 Univ"},{"key":"10738_CR27","unstructured":"National Comprehensive Cancer Network (NCCN), NCCN Guidelines for Patients\u00ae: Bladder Cancer (2024) NCCN.org\/patientguidelines"},{"key":"10738_CR28","doi-asserted-by":"publisher","unstructured":"Holzbeierlein J, Bixler BR, Buckley DI, Chang SS, Holmes RS, James AC, Kirkby E, McKiernan JM, Schuckman A (2017) Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA\/ASCO\/SUO Guideline; Amended 2020, 2024), J Urol. 212 (2024) 3\u201310. https:\/\/doi.org\/10.1097\/JU.0000000000003981","DOI":"10.1097\/JU.0000000000003981"},{"key":"10738_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10549-011-1693-x","volume":"133","author":"C Panis","year":"2012","unstructured":"Panis C, Herrera ACSA, Victorino VJ, Campos FC, Freitas LF, De Rossi T, Colado Sim\u00e3o AN, Cecchini AL, Cecchini R (2012) Oxidative stress and hematological profiles of advanced breast cancer patients subjected to Paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 133:89\u201397. https:\/\/doi.org\/10.1007\/s10549-011-1693-x","journal-title":"Breast Cancer Res Treat"},{"key":"10738_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, Creighton CJ, Varambally S (2022) UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 25:18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001","journal-title":"Neoplasia"},{"key":"10738_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio Cancer genomics portal: an open platform for exploring multidimensional Cancer genomics data. Cancer Discov 2:401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"key":"10738_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","journal-title":"Cancer Discov"},{"key":"10738_CR33","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/febs.14654","volume":"286","author":"H Almuttaqi","year":"2019","unstructured":"Almuttaqi H (2019) Advances and challenges in targeting IRF5, a key regulator of inflammation. FEBS J 286:1624\u20131637. https:\/\/doi.org\/10.1111\/febs.14654","journal-title":"FEBS J"},{"key":"10738_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.4049\/jimmunol.0901748","volume":"184","author":"C Richez","year":"2010","unstructured":"Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, Richards RJ, Liu CL, Cheung R, Utz PJ, Marshak-Rothstein A, Rifkin IR (2010) IFN regulatory factor 5 is required for disease development in the Fc\u03b3RIIB\u2013\/\u2013Yaa and Fc\u03b3RIIB\u2013\/\u2013 mouse models of systemic lupus erythematosus. J Immunol 184:796\u2013806. https:\/\/doi.org\/10.4049\/jimmunol.0901748","journal-title":"J Immunol"},{"key":"10738_CR35","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/ijc.33359","volume":"148","author":"E Wieczorek","year":"2021","unstructured":"Wieczorek E, Garstka MA (2021) Recurrent bladder cancer in aging societies: importance of major histocompatibility complex class I antigen presentation. Intl J Cancer 148:1808\u20131820. https:\/\/doi.org\/10.1002\/ijc.33359","journal-title":"Intl J Cancer"},{"key":"10738_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","volume":"22","author":"X Wu","year":"2023","unstructured":"Wu X, Li T, Jiang R, Yang X, Guo H, Yang R (2023) Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Mol Cancer 22:194. https:\/\/doi.org\/10.1186\/s12943-023-01899-4","journal-title":"Mol Cancer"},{"key":"10738_CR37","doi-asserted-by":"publisher","first-page":"1383304","DOI":"10.3389\/fphar.2024.1383304","volume":"15","author":"W Kang","year":"2024","unstructured":"Kang W, Ye C, Yang Y, Lou Y-R, Zhao M, Wang Z, Gao Y (2024) Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer. Front Pharmacol 15:1383304. https:\/\/doi.org\/10.3389\/fphar.2024.1383304","journal-title":"Front Pharmacol"},{"key":"10738_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","volume":"9","author":"L Wang","year":"2024","unstructured":"Wang L, Zhu Y, Zhang N, Xian Y, Tang Y, Ye J, Reza F, He G, Wen X, Jiang X (2024) The multiple roles of interferon regulatory factor family in health and disease. Sig Transduct Target Ther 9:282. https:\/\/doi.org\/10.1038\/s41392-024-01980-4","journal-title":"Sig Transduct Target Ther"},{"key":"10738_CR39","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204863","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhu H, Xu H, Qiu Y, Zhu Y, Wang X (2023) Senescence-related gene c-Myc affects bladder cancer cell senescence by interacting with HSP90B1 to regulate cisplatin sensitivity. Aging. https:\/\/doi.org\/10.18632\/aging.204863","journal-title":"Aging"},{"key":"10738_CR40","doi-asserted-by":"publisher","first-page":"e12102","DOI":"10.1016\/j.heliyon.2022.e12102","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang J, Chen S, Wang H, Cao J, Fan X, Man J, Li Q, Yang L (2022) Integrated molecular analyses of an interferon-\u03b3 based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification. Heliyon 8:e12102. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12102","journal-title":"Heliyon"},{"key":"10738_CR41","first-page":"969","volume":"41","author":"S Nakata","year":"1995","unstructured":"Nakata S, Sato J, Ohtake N, Imai K, Yamanaka H (1995) [Epidemiological study of risk factors for bladder cancer]. Hinyokika Kiyo 41:969\u2013977","journal-title":"Hinyokika Kiyo"},{"key":"10738_CR42","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1002\/ijc.31597","volume":"143","author":"S Teleka","year":"2018","unstructured":"Teleka S, H\u00e4ggstr\u00f6m C, Nagel G, Bj\u00f8rge T, Manjer J, Ulmer H, Liedberg F, Ghaderi S, Lang A, Jonsson H, Jahnson S, Orho-Melander M, Tretli S, Stattin P, Stocks T (2018) Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women. Intl J Cancer 143:3071\u20133082. https:\/\/doi.org\/10.1002\/ijc.31597","journal-title":"Intl J Cancer"},{"key":"10738_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/03009734.2018.1473534","volume":"123","author":"VC Kok","year":"2018","unstructured":"Kok VC, Zhang H-W, Lin C-T, Huang S-C, Wu M-F (2018) Positive association between hypertension and urinary bladder cancer: epidemiologic evidence involving 79,236 propensity score-matched individuals. Ups J Med Sci 123:109\u2013115. https:\/\/doi.org\/10.1080\/03009734.2018.1473534","journal-title":"Ups J Med Sci"},{"key":"10738_CR44","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/carcin\/bgq173","volume":"31","author":"X Jiang","year":"2010","unstructured":"Jiang X, Castelao JE, Yuan J-M, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M (2010) Hypertension, diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis 31:1964\u20131971. https:\/\/doi.org\/10.1093\/carcin\/bgq173","journal-title":"Carcinogenesis"},{"key":"10738_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc2945","volume":"10","author":"AJ George","year":"2010","unstructured":"George AJ, Thomas WG, Hannan RD (2010) The renin\u2013angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 10:745\u2013759. https:\/\/doi.org\/10.1038\/nrc2945","journal-title":"Nat Rev Cancer"},{"key":"10738_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/21681805.2019.1634147","volume":"53","author":"EEE Santala","year":"2019","unstructured":"Santala EEE, Kotsar A, Veitonm\u00e4ki T, Tammela TLJ, Murtola TJ (2019) Risk of urothelial cancer death among people using antihypertensive drugs\u2014a cohort study from Finland. Scandinavian J Urol 53:185\u2013192. https:\/\/doi.org\/10.1080\/21681805.2019.1634147","journal-title":"Scandinavian J Urol"},{"key":"10738_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-0774.2007.00025.x","volume":"20","author":"M Kosugi","year":"2007","unstructured":"Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M (2007) Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer. Hum Cell 20:1\u20139. https:\/\/doi.org\/10.1111\/j.1749-0774.2007.00025.x","journal-title":"Hum Cell"},{"key":"10738_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.cr.7290133","volume":"12","author":"W Xu","year":"2002","unstructured":"Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG (2002) The role of nitric oxide in cancer. Cell Res 12:311\u2013320. https:\/\/doi.org\/10.1038\/sj.cr.7290133","journal-title":"Cell Res"},{"key":"10738_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/vaccines9020094","volume":"9","author":"J Mintz","year":"2021","unstructured":"Mintz J, Vedenko A, Rosete O, Shah K, Goldstein G, Hare JM, Ramasamy R, Arora H (2021) Current advances of nitric oxide in Cancer and anticancer therapeutics. Vaccines 9:94. https:\/\/doi.org\/10.3390\/vaccines9020094","journal-title":"Vaccines"},{"key":"10738_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/biomedicines11010199","volume":"11","author":"M Varela","year":"2023","unstructured":"Varela M, L\u00f3pez M, Ingold M, Alem D, Perini V, Perelmuter K, Bollati-Fogol\u00edn M, L\u00f3pez GV, Hern\u00e1ndez P (2023) New nitric Oxide-Releasing compounds as promising Anti-Bladder Cancer drugs. Biomedicines 11:199. https:\/\/doi.org\/10.3390\/biomedicines11010199","journal-title":"Biomedicines"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10738-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10738-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10738-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:24:58Z","timestamp":1766895898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10738-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10738"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10738-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the principles of the Declaration of Helsinki and approved by the Institutional Research Ethics Committees of the University of Londrina, Paran\u00e1, Brazil (CAAE: 47092521.2.0000.5231). All invited individuals were informed in detail about the research and signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The study participants were informed about the present research, and written informed consent was obtained from them before their enrollment. Furthermore, all authors and co-authors participated in and contributed sufficiently to the study, and all agreed to the submission. The responsible authorities approved the manuscript in which the work was conducted. The authors also agree that, if accepted, the manuscript will not be published elsewhere in the same form, neither in the same nor in any other language, without the consent of the Editor of Molecular Biology Reports.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"649"}}